Guanosine pentaphosphate
Guanosine pentaphosphate (also known as pppGpp) is a guanosine derivative that is involved in the stringent response, a regulatory response to amino acid starvation in bacteria. It is a nucleotide composed of guanosine and five phosphate groups.
Structure[edit]
Guanosine pentaphosphate is a guanosine triphosphate (GTP) derivative with two additional phosphate groups. The guanosine molecule is attached to a chain of five phosphate groups, hence the name "pentaphosphate". The structure of pppGpp is similar to that of other guanosine phosphates, with the addition of the two extra phosphate groups.
Function[edit]
Guanosine pentaphosphate plays a crucial role in the stringent response, a regulatory mechanism in bacteria that responds to amino acid starvation. When amino acids are scarce, the production of pppGpp increases. This molecule then binds to the RNA polymerase, inhibiting the transcription of rRNA and tRNA genes, which are involved in protein synthesis. This allows the bacteria to conserve resources until conditions improve.
In addition to its role in the stringent response, pppGpp also regulates other cellular processes. For example, it has been shown to inhibit the activity of GTPase enzymes, which are involved in signal transduction and protein synthesis.
Biosynthesis[edit]
The biosynthesis of guanosine pentaphosphate is catalyzed by the enzyme RelA. When amino acids are scarce, uncharged tRNA molecules accumulate in the cell. These uncharged tRNAs bind to the ribosome, triggering the activation of RelA. This enzyme then catalyzes the conversion of GTP to pppGpp.
Role in disease[edit]
Alterations in the levels of pppGpp have been associated with various diseases. For example, high levels of this molecule have been found in patients with tuberculosis, suggesting a role in the pathogenesis of this disease. Furthermore, some bacteria use the stringent response to survive in hostile environments, such as those encountered within the human body during infection.
See also[edit]
References[edit]
<references />
Guanosine pentaphosphate gallery[edit]
-
PppGpp
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
